Trials / Withdrawn
WithdrawnNCT00406172
Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Asociación para Evitar la Ceguera en México · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
To report safety and efficacy of intravitreal injection of bevacizumab in patients with cystoid macular edema secondary to cataract surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bevacizumab |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2006-11-01
- Completion
- 2006-11-01
- First posted
- 2006-12-04
- Last updated
- 2024-06-05
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT00406172. Inclusion in this directory is not an endorsement.